Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 21,938	$ 12,582	$ 46,333	$ 23,932
General and administrative	5,719	4,892	11,355	9,942
Total operating expenses	27,657	17,474	57,688	33,874
Loss from operations	(27,657)	(17,474)	(57,688)	(33,874)
Interest and other income, net	2,766	216	3,746	250
Net loss	(24,891)	(17,258)	(53,942)	(33,624)
Other comprehensive loss:
Unrealized gain (loss) on investments, net		6	1	(7)
Comprehensive loss	$ (24,891)	$ (17,252)	$ (53,941)	$ (33,631)
Net loss per common share, basic	$ (0.70)	$ (0.59)	$ (1.66)	$ (1.15)
Net loss per common share, diluted	$ (0.70)	$ (0.59)	$ (1.66)	$ (1.15)
Weighted-average number of common shares used to compute basic net loss per common share	35,348,293	29,196,398	32,483,297	29,161,437
Weighted-average number of common shares used to compute diluted net loss per common share	35,348,293	29,196,398	32,483,297	29,161,437